These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15117849)

  • 1. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease.
    Kiechl S; Schett G; Wenning G; Redlich K; Oberhollenzer M; Mayr A; Santer P; Smolen J; Poewe W; Willeit J
    Circulation; 2004 May; 109(18):2175-80. PubMed ID: 15117849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
    J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble RANKL and risk of nontraumatic fracture.
    Schett G; Kiechl S; Redlich K; Oberhollenzer F; Weger S; Egger G; Mayr A; Jocher J; Xu Q; Pietschmann P; Teitelbaum S; Smolen J; Willeit J
    JAMA; 2004 Mar; 291(9):1108-13. PubMed ID: 14996780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble receptor activator of nuclear factor-kappa B ligand and risk for cardiovascular disease.
    Kiechl S; Schett G; Schwaiger J; Seppi K; Eder P; Egger G; Santer P; Mayr A; Xu Q; Willeit J
    Circulation; 2007 Jul; 116(4):385-91. PubMed ID: 17620507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma osteoprotegerin is associated with mortality in hemodialysis patients.
    Morena M; Terrier N; Jaussent I; Leray-Moragues H; Chalabi L; Rivory JP; Maurice F; Delcourt C; Cristol JP; Canaud B; Dupuy AM
    J Am Soc Nephrol; 2006 Jan; 17(1):262-70. PubMed ID: 16280472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis.
    Schoppet M; Al-Fakhri N; Franke FE; Katz N; Barth PJ; Maisch B; Preissner KT; Hofbauer LC
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4104-12. PubMed ID: 15292354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis: prospective results from the Bruneck Study.
    Kiechl S; Werner P; Egger G; Oberhollenzer F; Mayr M; Xu Q; Poewe W; Willeit J
    Stroke; 2002 Sep; 33(9):2170-6. PubMed ID: 12215582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
    Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis.
    Granchi D; Pellacani A; Spina M; Cenni E; Savarino LM; Baldini N; Giunti A
    J Bone Joint Surg Am; 2006 Jul; 88(7):1501-9. PubMed ID: 16818976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum-soluble heat shock protein 60 with carotid atherosclerosis: clinical significance determined in a follow-up study.
    Xiao Q; Mandal K; Schett G; Mayr M; Wick G; Oberhollenzer F; Willeit J; Kiechl S; Xu Q
    Stroke; 2005 Dec; 36(12):2571-6. PubMed ID: 16254226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study.
    Wiedermann CJ; Kiechl S; Dunzendorfer S; Schratzberger P; Egger G; Oberhollenzer F; Willeit J
    J Am Coll Cardiol; 1999 Dec; 34(7):1975-81. PubMed ID: 10588212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteoprotegerin: regulator, protector and marker].
    El Hadj Othmane T; Speer G; Fekete B; Szabó T; Egresits J; Fodor E; Kiss I; Nemcsik J; Szabó A; Németh Z; Szathmári M; Tislér A
    Orv Hetil; 2008 Oct; 149(42):1971-80. PubMed ID: 18842549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis.
    Schoppet M; Sattler AM; Schaefer JR; Hofbauer LC
    Atherosclerosis; 2006 Feb; 184(2):446-7. PubMed ID: 16325821
    [No Abstract]   [Full Text] [Related]  

  • 14. Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women.
    Browner WS; Lui LY; Cummings SR
    J Clin Endocrinol Metab; 2001 Feb; 86(2):631-7. PubMed ID: 11158021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction.
    Ueland T; Jemtland R; Godang K; Kjekshus J; Hognestad A; Omland T; Squire IB; Gullestad L; Bollerslev J; Dickstein K; Aukrust P
    J Am Coll Cardiol; 2004 Nov; 44(10):1970-6. PubMed ID: 15542278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment.
    Rogers A; Eastell R
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6323-31. PubMed ID: 16105967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1.
    Park YJ; Shin YJ; Kim WU; Cho CS
    Lupus; 2014 Mar; 23(3):236-44. PubMed ID: 24531425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction.
    Geusens PP; Landewé RB; Garnero P; Chen D; Dunstan CR; Lems WF; Stinissen P; van der Heijde DM; van der Linden S; Boers M
    Arthritis Rheum; 2006 Jun; 54(6):1772-7. PubMed ID: 16736519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum osteoprotegerin values in long-lived subjects: different effects of inflammation and bone metabolism.
    Mazziotti G; Amato G; Sorvillo F; Piscopo M; Rizzo MR; Lalli E; Iride L; Cioffi M; Molinari AM; Paolisso G; Carella C
    Eur J Endocrinol; 2006 Mar; 154(3):373-7. PubMed ID: 16498049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein predicts future cardiovascular events in patients with carotid stenosis.
    Schlager O; Exner M; Mlekusch W; Sabeti S; Amighi J; Dick P; Wagner O; Koppensteiner R; Minar E; Schillinger M
    Stroke; 2007 Apr; 38(4):1263-8. PubMed ID: 17322087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.